Novartis Updating Tekturna Label with Warnings for Diabetes, Kidney Patients. Announces Valturna Market Withdrawal
Tekturna Label Are Being Updated With Warnings. Novartis has announced that it will be making changes to the labels for Tekturna and other aliskiren-based medications regarding serious risks posed by such drugs when they are used by diabetics or patients with kidney failure who are also taking ACE Inhibitors or angiotensin receptor … [Read more...] about Novartis Updating Tekturna Label with Warnings for Diabetes, Kidney Patients. Announces Valturna Market Withdrawal
Blood Pressure Drug, Tekturna Linked to Kidney Problems and/or Stroke
Blood Pressure Drug Has Been Linked To Kidney Problems. Tekturna (aliskiren) is a medication manufactured by Novartis that is used to treat high blood pressure, but it might also lead to complications such as a stroke, kidney problems, potentially deadly sensitivity and other side effects. In fact, this drug raised so many … [Read more...] about Blood Pressure Drug, Tekturna Linked to Kidney Problems and/or Stroke
Tekturna Deadly Complications
Blood Pressure Medication Tekturna Linked to Potentially Deadly Complications. Parker Waichman LLP is reporting that Tekturna, a drug used to treat hypertension, is associated with potentially fatal side effects. According to a report by the Institute for Safe Medication Practices (ISMP), the U.S. Food and Drug Administration (FDA) … [Read more...] about Tekturna Deadly Complications
Novartis Updating Tekturna Label with Warnings
/category/defective-drugs/tekturna Novartis Updating Tekturna Label. Novartis has announced that it will be making changes to the labels for Tekturna and other aliskiren-based medications regarding serious risks posed by such drugs when they are used by diabetics or patients with kidney failure who are also taking ACE … [Read more...] about Novartis Updating Tekturna Label with Warnings
U.K. Regulator Issues Aliskiren Update
Drug Safety Update Issued For Tekturna. U.K.'s health regulator has issued a Drug Safety Update detailing new contraindications for diabetics and kidney patients using the blood pressure drug, aliskiren (marketed as Rasilez and Tekturna). According to the Medicine and Healthcare Products Regulatory Agency (MHRA), the use … [Read more...] about U.K. Regulator Issues Aliskiren Update
